Literature DB >> 15372523

Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis.

Sara Shanske1, Jacklyn Pancrudo, Petra Kaufmann, Kristin Engelstad, Sarah Jhung, Jiesheng Lu, Ali Naini, Salvatore DiMauro, Darryl C De Vivo.   

Abstract

Testing for common mutations in mitochondrial DNA (mtDNA), including the A3243G MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) mutation, is routinely done in DNA isolated from blood. Since the blood level of the A3243G mutation may be low in probands and even lower in asymptomatic or oligosymptomatic maternal relatives, we assessed the proportion of A3243G mutant genomes in other accessible tissues. We studied five tissues (leukocytes, skin fibroblasts, hair roots, urinary sediment, and cheek mucosa) in 61 individuals from 22 families harboring the A3243G mutation. Although mutational loads varied widely among these tissues, as a rule DNA from urinary sediment had the highest and blood the lowest proportion of mutant genomes; individual hair roots differed markedly from one another; fibroblasts and cheek mucosa tended to have higher mutation loads than blood but lower than urinary sediment. In all individuals in whom the mutation was detectable in blood, it was also detected in other tissues. Conversely, in some individuals the mutation was undetectable in blood but clearly present in other tissues. We conclude that urinary sediment and cheek mucosa are tissues of choice for the diagnosis of mtDNA mutations, as they are easy to obtain and the mutation load is almost always greater than in blood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372523     DOI: 10.1002/ajmg.a.30220

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

Review 1.  A diagnostic algorithm for metabolic myopathies.

Authors:  Andres Berardo; Salvatore DiMauro; Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

2.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

3.  Tissue specific distribution of the 3243A->G mtDNA mutation.

Authors:  A L Frederiksen; P H Andersen; K O Kyvik; T D Jeppesen; J Vissing; M Schwartz
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

4.  Pitfalls in the denaturing high-performance liquid chromatography analysis of mitochondrial DNA mutation.

Authors:  Kok Seong Lim; Robert K Naviaux; Scott Wong; Richard H Haas
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 5.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

6.  Extensive tissue-related and allele-related mtDNA heteroplasmy suggests positive selection for somatic mutations.

Authors:  Mingkun Li; Roland Schröder; Shengyu Ni; Burkhard Madea; Mark Stoneking
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 7.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  Slowly progressive encephalopathy with hearing loss due to a mutation in the mtDNA tRNA(Leu(CUN)) gene.

Authors:  Jorida Coku; Sara Shanske; Mahsa Mehrazin; Kurenai Tanji; Ali Naini; Valentina Emmanuele; Marc Patterson; Michio Hirano; Salvatore DiMauro
Journal:  J Neurol Sci       Date:  2009-12-22       Impact factor: 3.181

9.  Targeted exome sequencing of suspected mitochondrial disorders.

Authors:  Daniel S Lieber; Sarah E Calvo; Kristy Shanahan; Nancy G Slate; Shangtao Liu; Steven G Hershman; Nina B Gold; Brad A Chapman; David R Thorburn; Gerard T Berry; Jeremy D Schmahmann; Mark L Borowsky; David M Mueller; Katherine B Sims; Vamsi K Mootha
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

10.  Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene.

Authors:  Johan L K Van Hove; Cynthia Freehauf; Shelley Miyamoto; Georgirene D Vladutiu; Jacklyn Pancrudo; Eduardo Bonilla; Mark A Lovell; Gary W Mierau; Janet A Thomas; Sara Shanske
Journal:  Eur J Pediatr       Date:  2007-09-22       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.